Prescription for Savings

Congress can take meaningful action to lower prescription drug costs for patients who rely on affordable medicines to live healthy lives.

Learn More
State-by-State Savings

To view a full break down of generic savings by state and payer type, view our interactive U.S. map.

View Map
Generic Drugs are the Prescription for Savings

More than 9 out of 10 generic drug prescriptions are filled for $20 or less.

View Infographic
Preserve Patient Access in Trade Agreements

The new trade agreement (USMCA) keeps drug prices high, for longer and creates new barriers to competition from generics and biosimilars. Without action, drug prices will remain out of reach for Americans.

Learn More

Working to leave a positive impact on...

Industry

We promote competition in the pharmaceutical industry by lowering barriers to entry for manufacturers and combatting anti-competitive abuses by some brand drug companies who put profits before patients. Learn More

People

We measure our success as an industry by the lives we impact. We work to protect the low cost of current drugs and to drive down the cost of developing new ones, expanding access to as many people as possible. Learn More

Society

We are a trusted partner and established authority within the pharmaceutical field. We provide accurate, timely data to educate policymakers and promote general public knowledge regarding the positive impact of affordable medicines. Learn More

About Us

The Association for Accessible Medicines, formerly the Generic Pharmaceutical Association, improves access to safe, quality, effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.

Health is the foundation for everything in life. Healthy people are better able to reach their full potential. Generics and biosimilars help more people in more places live healthier and longer.

Recent Updates

AAM Welcomes the Re-introduction of the PACED Act

Feb 13, 2019 | Rachel Schwartz

AAM Welcomes Re-Introduction of the PACED Act

Pass CREATES Act - lower prescription drug prices for patients

Feb 8, 2019 | Rachel Schwartz

Statement from the Association for Accessible Medicines on the Introduction of the CREATES Act

Congress Should Reject Hatch-Waxman Act of 2019

Feb 7, 2019 | Rachel Schwartz

AAM: Congress Should Reject Hatch-Waxman Integrity Act of 2019

Alex Azar - HHS Secretary Live from Access! 2019

Feb 6, 2019 | Allen Goldberg

Alex Azar to Speak at Access! 2019

AAM Announces 2019 Board of Directors

Feb 4, 2019 | Rachel Schwartz

AAM Announces 2019 Board of Directors

Trump Targeting Backdoor Rebates - Lower Drug Prices

Feb 1, 2019 | Rachel Schwartz

AAM Statement on Trump Administration’s Proposal to Lower Drug Costs by Targeting Backdoor Rebates